American International Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-32,468
| Closed | -$431K | – | 2627 |
|
|
2024
Q1 | $431K | Buy |
32,468
+6,517
| +25% | +$86.5K | ﹤0.01% | 1737 |
|
|
2023
Q4 | $362K | Buy |
25,951
+633
| +3% | +$8.82K | ﹤0.01% | 1844 |
|
|
2023
Q3 | $336K | Buy |
25,318
+900
| +4% | +$11.9K | ﹤0.01% | 1829 |
|
|
2023
Q2 | $458K | Buy |
24,418
+1,850
| +8% | +$34.7K | ﹤0.01% | 1695 |
|
|
2023
Q1 | $325K | Buy |
22,568
+449
| +2% | +$6.48K | ﹤0.01% | 1839 |
|
|
2022
Q4 | $428K | Buy |
22,119
+518
| +2% | +$10K | ﹤0.01% | 1685 |
|
|
2022
Q3 | $742K | Buy |
21,601
+4,313
| +25% | +$148K | 0.01% | 1346 |
|
|
2022
Q2 | $264K | Sell |
17,288
-807
| -4% | -$12.3K | ﹤0.01% | 2000 |
|
|
2022
Q1 | $413K | Buy |
18,095
+9,698
| +115% | +$221K | ﹤0.01% | 1829 |
|
|
2021
Q4 | $310K | Sell |
8,397
-251
| -3% | -$9.27K | ﹤0.01% | 2096 |
|
|
2021
Q3 | $406K | Buy |
+8,648
| New | +$406K | ﹤0.01% | 1996 |
|